Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Asparaginase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia 18 Lymphoma 6 Leukemia, Myeloid, Acute 5 Burkitt Lymphoma 4 Myelodysplastic Syndromes 3 Anemia, Refractory, with Excess of Blasts 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Erythroblastic, Acute 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Biphenotypic, Acute 2 Down Syndrome 2 Anemia, Refractory 2 Sarcoma, Myeloid 1 Recurrence 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Basophilic, Acute 1 Drug-Related Side Effects and Adverse Reactions 1 Dendritic Cell Sarcoma, Interdigitating 1 Congenital Abnormalities 1 Cardiotoxicity 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 7 Prednisone 7 Drug Therapy 7 Doxorubicin 7 Anastrozole 7 Rituximab 6 Ondansetron 6 Morphine 6 Irinotecan 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03665441 2022-10-18

Trybeca-1

ERYtech Pharma

Phase 3 Completed

512 enrolled 19 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡